Synthesis and binding affinity of a fluorine-substituted peroxisome proliferator-activated gamma (PPARγ) ligand as a potential positron emission tomography (PET) imaging agent

Bioconjugate Chemistry

Volumn 18, Issue 2, 2007, Pages 507-513

  Lee, Byung Chul ^a   Lee, Kyo Chul ^b   Lee, Hsiaoju ^c   Mach, Robert H ^c   Katzenellenbogen, John A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BINDING ENERGY; CHELATION; CYTOLOGY; FLUORINE; FLUORINE COMPOUNDS; LIGANDS; METABOLISM; PHYSIOLOGY; POSITRONS;

ADIPOCYTES; BINDING AFFINITIES; CELL DIFFERENTIATION; IMAGING AGENT; IN-VIVO; LIPID METABOLISMS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PEROXISOME PROLIFERATORS; TOMOGRAPHY IMAGING; TUMOUR CELLS;

POSITRON EMISSION TOMOGRAPHY;

BENZOPHENONE; COPPER; FARGLITAZAR; FLUORIDE ION; FLUORINE 18; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PROPIONIC ACID DERIVATIVE; SB 213068; TYROSINE; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG; [2 (4 FLUOROBENZOYL)PHENYLAMINO] 3 [4 [2 (5 METHYL 2 PHENYLOXAZOL 4 YL)ETHOXY]PHENYL]PROPIONIC ACID;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CATALYSIS; CATALYST; CELL DIFFERENTIATION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; LIPID METABOLISM; POLYMERIZATION; POSITRON EMISSION TOMOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; RECEPTOR AFFINITY; TUMOR CELL; ULLMAN CONDENSATION;

EID: 33947704130     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc060190o     Document Type: Article

References (34)

1. Brun, R. P., Kim, J. B., Hu, E., and Spiegelman, B. M. (1997) Peroxisome proliferator-activated receptor gamma and the control of adipogenesis. Curr. Opin. Lipidol. 8, 212-218.
2. Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., and Lehmann, J. M. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83, 813-819.
3. Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., and Evans, R. M. (1994) Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. U.S.A. 91, 7355-7359.
4. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., and Spiegelman, B. M. (1994) mPPAR γ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234.
5. Mueller, E., Smith, M., Sarraf, P., Kroll, T., Aiyer, A., Kaufman, D. S., Oh, W., Demetri, G., Figg, W. D., Zhou, X. P., Eng, C., Spiegelman, B. M., and Kantoff, P. W. (2000) Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 97, 10990-10995.
6. Muller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C. D., Singer, S., and Spiegelman, B. M. (1998) Terminal differentiation of human breast cancer through PPAR gamma. Mol. Cell 1, 465-470.
7. Demetri, G. D., Fletcher, C. D. M., Mueller, E., Sarraf, F., Naujoks, R., Campbell, N., Spiegelman, B. M., and Singer, S. (1999) Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma. Proc. Natl. Acad. Sci. U.S.A. 96, 3951-3956.
8. Tontonoz, P., Singer, S., Froman, B. M., Sarraf, P., Fletcher, J. A., Fletcher, C. D. M., Brun, R. P., Mueller, E., Altiok, S., Oppenheim, H., Evans, R. M., and Spiegelman, B. M. (1997) Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor. Proc. Natl. Acad. Sci. U.S.A. 94, 237-241.
9. Burstein, H. J., Demetri, G. D., Muller, E., Sarraf, P., Spiegelman, B. M., and Winer, E. P. (2003) Use of the peroxisome proliferator-activated receptor (PPAR) γ ligand troglitazone as treatment for refractory breast cancer: a phase II study. Breast Cancer Res. Treat. 79, 391-397.
10. Wang, X., Southard, R. C., and Kilgore, M. W. (2004) The increased expression of peroxisome proliferator-activatated receptor-γ 1 in human breast cancer is mediated by selective promoter usage. Cancer Res. 64, 5592-5596.
11. Berger, J. P., Akiyama, T. E., and Meinke, P. T. (2005) PPARs: therapeutic targets for metabolic disease. Trends Pharmacol. Sci. 26, 244-251.
12. Kim, S-H., Jonson, S. D., Welch, M. J., and Katzenellenbogen, J. A. (2001) Fluorine-substituted ligands for the peroxisome proliferator-activated receptor gamma (PPARγ): Potential imaging agents for metastatic tumors. Bioconjugate Chem. 12, 439-450.
13. Henke, B. R., Blanchard, S. G., Brackeen, M. F., Brown, K. K., Cobb, J. E., Collins, J. L., Harrington, W. W., Jr., Hashim, M. A., Hull-Ryde, E. A., Kaldor, I., Kliewer, S. A., Lake, D. H., Leesnitzer, L. M., Lehmann, J. M., Lenhard, J. M., Orband-Miller, L. A., Miller, J. F., Mook, R. A., Jr., Noble, S. A., Oliver, W., Jr., Parks, D. J., Plunket, K. D., Szewczyk, J. R., and Willson, T. M. (1998) N-(2-Benzoylphenyl)-L-tyrosine PPARγ agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. J. Med. Chem. 41, 5020-5036.
14. Collins, J. L., Blanchard, S. G., Boswell, E. G., Charifson, P. S., Cobb, J. E., Henke, B. R., Hull-Ryde, E. A., Kazmierski, W. M., Lake, D. H., Leesnitzer, L. M., Lehmann, J., Lenhard, J. M., Orband-Miller, L. A., Gray-Nunez, Y., Parks, D. J., Plunkett, K. D., and Tong, W. Q. (1998) N-(2-Benzoylphenyl)-L-tyrosine PPARγ agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety. J. Med. Chem. 41, 5037-5054.
15. Cobb, J. E., Blanchard, S. G., Boswell, E. G., Brown, K. K., Charifson, P. S., Cooper, J. P., Collins, J. L., Dezube, M., Henke, B. R., Hull-Ryde, E. A., Lake, D. H., Lenhard, J. M., Oliver, W. Jr., Oplinger, J., Pentti, M., Parks, D. J., Plunket, K. D., and Tong, W. Q. (1998) N-(2-Benzoylphenyl)- L-tyrosine PPARγ agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent. J. Med. Chem. 41, 5055-5069.
16. Willson, T. M., Brown, P. J., Sternbach, D. D., and Henke, B. R. (2000) The PPARs: From orphan receptors to drug discovery. J. Med. Chem 43, 527-550.
17. Pangborn, A. B., Giardello, M. A., Grubbs, R. H., Rosen, R. K., and Timmer, F. J. (1996) Safe and convenient procedure for solvent purification. Organometallics 15, 1518-1520.
18. Schlienger, N., Peyrottes, S., Kassem, I., Inibach, I.-L., Gosselin, G., Aubertin, A-M., and Périgaud, C. (2000) S-Acyl-2-thioethyl aryl phosphotriester derivatives as mononucleotide prodrags. J. Med. Chem. 43, 4570-4574.
19. Hulin, B., Clark, D. A., Goldstein, S. W., McDermott, R. E., Dambek, P. J., Kappeler, W. H., Lamphere, C. H., Lewis, D. M., and Rizzi, J. P. (1992) Novel thiazolidine-2,4-diones as potent euglycemic agents. J. Med. Chem. 35, 1853-1864.
20. Tuemmler, W. B., and Wildi, B. S. (1958) Polymethine dyes. I. A comparison of several vinylogous series in which the polymethine chains are terminated by aryl groups. J. Am. Chem. Soc. 80, 3772-3777.
21. Sun, S., Almaden, J., Carlson, T. J., Barker, J., and Gehring, M. R. (2005) Assay development and data analysis of receptor-ligand binding based on scintillation proximity assay. Metab. Eng. 7, 38-44.
22. Brown, K. K., Henke, B. R., Blanchard, S. G., Cobb, J. E., Mook, R., Kaldor, I., Kliewer, S. A., Lehmann, J. M., Lenhard, J. M., Harrington, W. W., Novak, P. J., Faison, W., Binz, J. G., Hashim, M. A., Oliver, W. O., Brown, H. R., Parks, D. J., Plunket, K. D., Tong, W. Q., Menius, J. A., Adkison, K., Noble, S. A., and Wilson, T. M. (1999) A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat. Diabetes 48, 1415-1424.
23. Campbell, R. D., and Gilow, H. N. (1960) β-Diketones. I. Synthesis and reactions of some 2-benzoylcyclanones. J. Am. Chem. Soc. 82, 2389-2393.
24. 18F-radiofluorinations of aromatic molecules. Appl. Radiat. Isot. 44, 889-893.
25. 18F]fluorophenol. Nucl. Med. Biol. 29, 255-262.
26. 18F]GBR-13119. J. Label. Comp. Radiopharm. 27, 823-833.
27. Martin, L. L., Klioze, S. S., Worm, M., Crichlow, C. A., Geyer, H. M., III, and Kruse, H. (1979) Synthesis of spiro[isobenzofuran-1(3H), 4′-piperidines] as potential central nervous system agents. 5. Conformationally mobile analogs derived by furan ring opening. J. Med. Chem. 22, 1347-1354.
28. Ma, D., Zhang, Y., Yao, J., Wu, S., and Tao, F. (1998) Accelerating effect introduced by the structure of α-amino acid in the copper-catalyzed coupling reaction of aryl halides with α-amino acids. synthesis of benzolactam-V8. J. Am. Chem. Soc. 120, 12459-12467.
29. Ma, D., Cai, Q., and Zhang, H. (2003) Mild method for ullmann coupling reaction of amines and aryl halides. Org. Lett. 5, 2453-2455.
30. DoAmaral, J. R., Blanz, J. E., Jr., and French, F. A. (1969) Antimalarial activity of guanylhydrazone salts of aromatic ketones. I. Active substituent patterns. J. Med. Chem. 12, 21-25.
31. Gabbutt, C. D., Heron, B., and Instone, A. C. (2003) Control of the fading properties of photochromic 3,3-diaryl-3H-naphtho[2,1-b]pyrans. Heterocycles 60, 843-855.
32. Greenstein, J. P., and Winitz, M. (1961) Chemistry of the Amino Acids, Vol 1, p 569, Wiley, New York.
33. Xu, L.-W., Xia, C.-C., Li, J.-W., Li, F.-W., and Zhou, S.-L. (2004) Efficient palladium/copper cocatalyzed C-N coupling reaction of unactivated aryl bromide of iodide with amino acid under microwave heating. Catal. Commun. 5, 121-123.
34. Clement, J-B., Hayes, J. F., Sheldrake, H. M., Sheldrake, P. W., and Wells, A. S. (2001) Synthesis of SB-214857 using copper catalysed amination of arylbromides with L-aspartic acid. Synlett 9, 1423-1427.